You are here: Home » Reuters » News
Business Standard

Advent, Shanghai Pharma have not approached Stada - sources

Reuters  |  FRANKFURT/LONDON 

By Alexander Hübner and Pamela BarbagliaFRANKFURT/LONDON (Reuters) - German drug company Stada Arzneimittel AG has not been approached by Advent International or Shanghai Pharmaceuticals Holding with a counter offer, two sources close to the matter told Reuters on Monday. Rival buyout firms Bain and Cinven had offered to buy Stada in April, which seemed to end the contest to acquire the generic drug maker, but Bloomberg reported on Monday that Advent and Shanghai Pharmaceuticals are considering making an offer. (https://bloom.bg/2pPpTni). Bain and Cinven's offer of 65.28 euros per share ...

This article is no longer available in our repository.

There could be multiple reasons for this.

RECOMMENDED FOR YOU